Illinois Qualifying Conditions

The conditions that qualify for the Illinois Compassionate Use Act of Medicinal Cannabis Pilot Program are:

  • Acquired Immunodeficiency Syndrome (Aids)
  • Agitation of Alzheimer’s disease
  • Amyotrophic Lateral Sclerosis (ALS)
  • Arnold-Chiari malformation and Syringomelia
  • Cachexia/wasting syndrome
  • Cancer
  • Causalgia
  • Chronic Inflammatory Demyelinating Polyneuropathy
  • Crohn’s disease
  • CRPS (Complex Regional Pain Syndromes Type II)
  • Dystonia
  • Fibromyalgia (severe)
  • Fibrous dysplasia
  • Glaucoma
  • Hepatitis C
  • Human Immunodeficiency Virus (HIV)
  • Hydrocephalus
  • Interstitial Cystitis
  • Lupus
  • Multiple Sclerosis
  • Muscular dystrophy
  • Myasthenia Gravis
  • Myoclonus
  • Nail-patella syndrome
  • Neurofibromatosis
  • Parkinson’s disease
  • Post-concussion syndrome
  • Post-Traumatic Stress Disorder (PTSD)
  • RSD (Complex Regional Pain Syndromes Type I)
  • Residual limb pain
  • Rheumatoid arthritis (RA)
  • Seizures, including those characteristic of epilepsy (Starting January 1, 2015)
  • Sjorgren’s syndrome
  • Spinal cord disease, including, but not limited to arachnoiditis, Tarlov cysts, hydromyelia, syringomyelia
  • Spinal cord injury
  • Spinocerebellar Ataxia (SCA)
  • Terminal Illness
  • Tourette’s syndrome
  • Traumatic brain injury (TBI)